Suchergebnisse - "Moran, Mary M"

PubPharm (10)

1

Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron

enthalten in: Journal of patient-reported outcomes | 2023

von Di Fusco, M. | Sun, X. | Moran, M. | +6

2

Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron

enthalten in: Journal of patient-reported outcomes | 2023

von Di Fusco, M. | Sun, X. | Moran, M. | +6

3

Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron

enthalten in: Journal of patient-reported outcomes | 2023

von Di Fusco, M. | Sun, X. | Moran, M. | +6

4

Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US

enthalten in: Frontiers in pediatrics | 2023

von McGrath, L. | Moran, M. | Alfred, T. | +7

5

Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes : quality of life, symptoms, and work productivity among US adult outpatients

enthalten in: Journal of patient-reported outcomes | 2022

von Di Fusco, M. | Sun, X. | Moran, M. | +6

6

Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients

enthalten in: Journal of patient-reported outcomes | 2022

von Di Fusco, M. | Sun, X. | Moran, M. | +6

7

Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients

enthalten in: Journal of patient-reported outcomes | 2022

von Di Fusco, M. | Sun, X. | Moran, M. | +6

8

COVID-19 Epidemiology, Immunity, and Vaccine Development in Children : A Review

enthalten in: Vaccines | 2022

von Fergie, J. | Moran, M. | Cane, A. | +3

9

Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States

enthalten in: Journal of medical economics | 2022

von Di Fusco, M. | Marczell, K. | Deger, K. | +7

10

Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2

enthalten in: Journal of medical economics | 2021

von Di Fusco, M. | Moran, M. | Cane, A. | +8

1
[1]